CN105795302A - 一种调理保健固体饮料 - Google Patents
一种调理保健固体饮料 Download PDFInfo
- Publication number
- CN105795302A CN105795302A CN201610230174.6A CN201610230174A CN105795302A CN 105795302 A CN105795302 A CN 105795302A CN 201610230174 A CN201610230174 A CN 201610230174A CN 105795302 A CN105795302 A CN 105795302A
- Authority
- CN
- China
- Prior art keywords
- health
- conditioning health
- care
- parts
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 29
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 29
- 239000007787 solid Substances 0.000 title claims abstract description 29
- 230000036541 health Effects 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims description 17
- 239000012467 final product Substances 0.000 claims description 3
- 235000013373 food additive Nutrition 0.000 claims description 3
- 239000002778 food additive Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 6
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 6
- 229910052804 chromium Inorganic materials 0.000 abstract description 6
- 239000011651 chromium Substances 0.000 abstract description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract description 6
- 239000000047 product Substances 0.000 abstract description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract description 6
- 229930003231 vitamin Natural products 0.000 abstract description 6
- 235000013343 vitamin Nutrition 0.000 abstract description 6
- 239000011782 vitamin Substances 0.000 abstract description 6
- 229940088594 vitamin Drugs 0.000 abstract description 6
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 5
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 abstract description 4
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 abstract description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 4
- 229960002173 citrulline Drugs 0.000 abstract description 4
- 235000013477 citrulline Nutrition 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 229910052711 selenium Inorganic materials 0.000 abstract description 4
- 239000011669 selenium Substances 0.000 abstract description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract description 3
- 229930003268 Vitamin C Natural products 0.000 abstract description 3
- 229960000304 folic acid Drugs 0.000 abstract description 3
- 235000019152 folic acid Nutrition 0.000 abstract description 3
- 239000011724 folic acid Substances 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 239000013589 supplement Substances 0.000 abstract description 3
- 229960003080 taurine Drugs 0.000 abstract description 3
- 235000019154 vitamin C Nutrition 0.000 abstract description 3
- 239000011718 vitamin C Substances 0.000 abstract description 3
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 abstract description 2
- 240000007594 Oryza sativa Species 0.000 abstract description 2
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 2
- 235000019136 lipoic acid Nutrition 0.000 abstract description 2
- 235000009566 rice Nutrition 0.000 abstract description 2
- 229960002663 thioctic acid Drugs 0.000 abstract description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 2
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract 1
- 235000011130 ammonium sulphate Nutrition 0.000 abstract 1
- 239000001166 ammonium sulphate Substances 0.000 abstract 1
- 238000009395 breeding Methods 0.000 abstract 1
- 230000001488 breeding effect Effects 0.000 abstract 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 abstract 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract 1
- 229940107187 fructooligosaccharide Drugs 0.000 abstract 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 229930064664 L-arginine Natural products 0.000 description 3
- 235000014852 L-arginine Nutrition 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- -1 lipid peroxide Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- QNTKVQQLMHZOKP-NEJDVEAASA-N (2r,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-2-[[(2r,3s,4s,5r)-2-[[(2r,3s,4s,5r)-2-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]- Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QNTKVQQLMHZOKP-NEJDVEAASA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000113306 Monascus purpureus Species 0.000 description 1
- 235000002322 Monascus purpureus Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000736919 Pelodiscus sinensis Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- FFQKYPRQEYGKAF-UHFFFAOYSA-N carbamoyl phosphate Chemical compound NC(=O)OP(O)(O)=O FFQKYPRQEYGKAF-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical class [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- QNTKVQQLMHZOKP-UHFFFAOYSA-N fructofuranosylnystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OCC3(OC4C(C(O)C(O)C(CO)O4)O)C(C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 QNTKVQQLMHZOKP-UHFFFAOYSA-N 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 230000005709 nerve cell growth Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明涉及一种调理保健固体饮料，由以下重量配比的原料混合制成：硒酵母粉0.1‑0.3份；铬酵母粉0.02‑0.08份；低聚木糖粉0.5‑2份；低聚果糖粉1‑3份；L‑精氨酸盐酸盐1‑2份；L‑赖氨酸盐酸盐1‑2份；瓜氨酸0.1‑0.3份；牛磺酸0.1‑0.3份；硫酸氨糖0.5‑1份；乙酰氨糖0.1‑0.5份；硫辛酸0.001‑0.003份；肠溶缓释维生素C0.1‑0.5份；维生素(B6)0.1‑0.5份；维生素(B12)0.05‑0.15份；叶酸0.1‑0.3份；维生素(E)0.05‑0.1份；红曲米粉0.01‑0.03份；绞股蓝提取物2‑7份。本发明具有专门为亚健康人群研发，饮用方便、配方合理、营养丰富、及时补充人体所需、且能抑制病菌滋生、科学调理身体，是所有人尤其是亚健康人优选的养生保健品。
Description
技术领域
本发明涉及一种饮料配方，特别是一种调理保健固体饮料。
背景技术
随着社会的不断发展，生活节奏的加快和社会压力的增大，提高人们身体健康水平尤为重要。由于人们生活水平不断提高，对食品不断提出新的要求，营养保健品应运而生。许多营养保健品采用人参、冬虫夏草、灵芝。甲鱼、鹿茸等名贵中药材作为原料，价格昂贵，这些高档营养品只有少数人能够享用，而广大的亚健康人群享用不起。而且这些名贵的营养保健品对身体的保健作用是局部的，很难实现身体全面地自行调理，不能达到以食养生，以食防病的目的。另外，生活节奏的加快和社会压力的增大使得人们，尤其是上班族大多处于亚健康状态，很多人患上了三高症(高血压、高血糖、高血脂)和/或糖尿病等，对于这些病症西医没有太好的治疗方法，其治疗手段大多以控制病情发展为主，因此需要常年服药，这给患者带来极大的不便且费用昂贵；而食疗和中医对于人体的调节作用已经被人们所认同，通过中医原理“补不足，泻有余，致中和”，通过日常饮食的调节和控制，再配合良好的生活习惯以及适当的体育锻炼往往能够达到很好的效果。现有饮料大多为各种茶类、牛奶或者果汁，虽然能够止渴、消暑而且口味良好，但是功能单一、无保健功效。
发明内容
本发明的目的就是为了解决背景技术中的问题，提供一种调理保健固体饮料，该保健饮料营养丰富，且原料来源广泛。
为达到上述目的，本发明采用如下技术方案：一种调理保健固体饮料，由以下重量配比的原料混合制成：
对于本发明的一种优化，所述调理保健固体饮料由以下重量配比的原料混合制成：
对于本发明的一种优化，所述调理保健固体饮料由以下重量配比的原料混合制成：
对于本发明的一种优化，所述调理保健固体饮料优选由以下重量配比的原料混合制成：
对于本发明的一种优化，所述调理保健固体饮料按照以下方法制备得到：零下10-20度以下低温条件下将原料粉碎并混合均匀，然后磨成80目以上的超细粉，即得。
对于本发明的一种优化，所述调理保健固体饮料还包含食品添加剂。
本发明与背景技术相比，具有专门为亚健康人群研发，饮用方便、配方合理、营养丰富、及时补充人体所需、且能抑制病菌滋生、科学调理身体，是所有人尤其是亚健康人优选的养生保健品，具有很大的市场价值及社会价值；可以提高人体免疫力，改善人体微循环，对促进人体健康具有积极的作用；生产成本低，生产方法简便可行，具有很好的市场前景。
具体实施方式
实施例1：一种调理保健固体饮料，由以下重量配比的原料混合制成：
所述调理保健固体饮料按照以下方法制备得到：零下10-20度以下低温条件下将原料粉碎并混合均匀，然后磨成80目以上的超细粉，即得。所述调理保健固体饮料还包含食品添加剂。
实施例2：在实施例1的基础上，所述调理保健固体饮料由以下重量配比的原料混合制成：
实施例3：在实施例1的基础上，所述调理保健固体饮料由以下重量配比的原料混合制成：
实施例4：在实施例1的基础上，所述调理保健固体饮料优选由以下重量配比的原料混合制成：
上述各实施例中：
尽管这里参照本发明的解释性实施例对本发明进行了描述，但并不用以限制本发明，应该理解，本领域技术人员可以设计出很多其他的修改和实施方式，这些修改和实施方式将落在本申请公开的原则范围和精神之内。
硒酵母粉：硒酵母是一有机态硒制剂，具生物利用度高、毒性低、疗效确切等优点，具有保护细胞膜完整性，清除自由基，加快脂质过氧化物分解、抗氧化、增强机体免疫功能、心肌功能等药理作用；
铬酵母粉：具有能明显降胝血清胆固醇水平，减轻动脉硬化症状，能纠正缺铬儿童和长期肠外营养患者的糖耐量异常，能有效增加人体肌肉，减少脂肪；为人体必需微量元素铬的生物活性制剂,酵母铬不仅具有良好的降血糖、降血脂的效果,还能避免无机铬盐的毒性,调节人体糖、脂类和蛋白质代谢,是一种安全而高效的铬补充剂
低聚果糖粉：低聚果糖是指2～5个果糖基为链节，以一个葡萄糖基为链的端基，以果糖基→果糖连接键为主体骨架连结形成的碳水化合物。即是指1～4个果糖基以β-2，1键连接在蔗糖的D-果糖基上而形成的蔗果三糖(GF2)、蔗果四糖(GF3)、蔗果五糖(GF4)和蔗果六糖(GF5)的混合物。
L-精氨酸盐酸盐：其有效成份为L-精氨酸，用于医药可帮助伤口愈合，刺激免疫系统的发展，提升荷尔蒙的分泌，促进尿循环，降低血液中氨的含量，治疗血氨中毒。
L-赖氨酸盐酸盐：一种营养增补剂，其适用于营养不良，精神发育迟滞瓜氨酸：瓜氨酸是一种α-氨基酸，是从鸟氨酸及胺基甲酰磷酸盐在尿素循环中生成，或是通过一氧化氮合酶(NOS)催化精氨酸生成NO的副产物。瓜氨酸具有能够防治前列腺疾病、提高男性性功能、治疗L-精氨酸缺乏引起的相关疾病、抗衰老和增强免疫力、提高运动员肌肉力量与耐力等。
牛磺酸：牛磺酸在脑内的含量丰富、分布广泛，能明显促进神经系统的生长发育和细胞增殖、分化，且呈剂量依赖性，在脑神经细胞发育过程中起重要作用，具有提高神经传导和视觉机能，防止心血管病，改善内分泌状态，增强人体免疫等功能。
硫酸氨糖：其作用机理是阻断炎症，清淤祛痛，容易被身体易吸收,而且可以长期服用,对肠胃没有刺激作用。
乙酰氨糖：它在临床上是治疗风湿性及类风湿性关节炎的药物，用于临床增强人体免疫系统的功能，抑制癌细胞或纤维细胞的过度生长，对癌症和恶性肿癌起到抑制和治疗作用；对于各种炎症，能起到有效的治疗，对骨关节炎及关节疼痛也有治疗作用。[
硫辛酸：其是一种存在于线粒体的辅酶，类似维他命，能消除加速老化与致病的自由基。
肠溶缓释维生素C：一种慢慢在肠道里溶解释放，使得维生素C吸收更好。
维生素B6，其又称吡哆素，其包括吡哆醇、吡哆醛及吡哆胺，在体内以磷酸酯的形式存在，是一种水溶性维生素。
维生素B12，其又叫钴胺素，是唯一含金属元素的维生素。自然界中的维生素B12都是微生物合成的，高等动植物不能制造维生素B12。
叶酸：其有促进骨髓中幼细胞成熟的作用，人类如缺乏叶酸可引起巨红细胞性贫血以及白细胞减少症，对孕妇尤其重要。
维生素E：其能促进性激素分泌，使男子精子活力和数量增加；使女子雌性激素浓度增高，提高生育能力，预防流产
红曲米粉：其由由早稻米经发酵加工而成，多呈红色或暗红色，主要用于固体饮料的着色。
考虑到本产品的口感、营养搭配合理性要求，实施例4所述重量配比原料混合所制成的调理保健固体饮料，其口感最佳，营养搭配最合理，符合人体所需有效成分的吸收。
需要理解到的是：本实施例虽然对本发明作了比较详细的说明，但是这些说明，只是对本发明的简单说明，而不是对本发明的限制，任何不超出本发明实质精神内发明创造，均落入本发明的保护范围。
Claims (6)
1.一种调理保健固体饮料，其特征在于由以下重量配比的原料混合制成：
2.一种调理保健固体饮料，其特征在于由以下重量配比的原料混合制成：
3.一种调理保健固体饮料，其特征在于由以下重量配比的原料混合制成：
4.根据权利要求1所述的调理保健固体饮料，其特征在于其有效成分是由以下重量配比的原料混合制成：
5.根据权利要求1-4所述的调理保健固体饮料，其特征在于，所述调理保健固体饮料按照以下方法制备得到：零下10-20度以下低温条件下将原料粉碎并混合均匀，然后磨成80目以上的超细粉，即得。
6.权利要求1-4所述的调理保健固体饮料，其特征在于，所述调理保健固体饮料还包含食品添加剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610230174.6A CN105795302A (zh) | 2016-04-14 | 2016-04-14 | 一种调理保健固体饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610230174.6A CN105795302A (zh) | 2016-04-14 | 2016-04-14 | 一种调理保健固体饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105795302A true CN105795302A (zh) | 2016-07-27 |
Family
ID=56459251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610230174.6A Pending CN105795302A (zh) | 2016-04-14 | 2016-04-14 | 一种调理保健固体饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105795302A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109770150A (zh) * | 2019-03-29 | 2019-05-21 | 郑州新福瑞生物科技有限公司 | 一种改善微循环障碍的功能性固体饮料及其制备方法 |
| CN111493258A (zh) * | 2020-04-27 | 2020-08-07 | 郑州瑞普生物工程有限公司 | 一种快速补充能量及营养的固体饮料 |
| CN113317379A (zh) * | 2021-06-21 | 2021-08-31 | 韩孟泽 | 一种保健固态饮料及其制备方法 |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1528160A (zh) * | 2003-09-29 | 2004-09-15 | 黄鹏兴 | 一种新型的绞股蓝袋泡茶及其制法 |
| CN101569414A (zh) * | 2008-04-29 | 2009-11-04 | 安琪酵母股份有限公司 | 一种富含酵母硒和酵母葡聚糖的组合物 |
| WO2012050895A1 (en) * | 2010-09-28 | 2012-04-19 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
| CN102579768A (zh) * | 2011-01-05 | 2012-07-18 | 李翔 | 一种能增加人体体内一氧化氮合成组方及制备方法 |
| CN102652743A (zh) * | 2011-03-04 | 2012-09-05 | 林飞 | 一种促进人体生成一氧化氮的组方 |
| CN104146248A (zh) * | 2014-07-30 | 2014-11-19 | 广州施健生物科技有限公司 | 一种免疫营养组合物及其应用 |
| CN104187686A (zh) * | 2014-09-26 | 2014-12-10 | 洛阳华以生物工程有限公司 | 一种提高免疫力的保健品 |
| CN104187624A (zh) * | 2014-08-07 | 2014-12-10 | 逯明福 | 综合营养粉及其制备方法 |
| CN104366475A (zh) * | 2014-11-10 | 2015-02-25 | 罗会明 | 一种增强型保健品 |
| CN104784443A (zh) * | 2015-05-04 | 2015-07-22 | 威海御膳坊生物科技有限公司 | 一种辅酶q10复合制剂 |
-
2016
- 2016-04-14 CN CN201610230174.6A patent/CN105795302A/zh active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1528160A (zh) * | 2003-09-29 | 2004-09-15 | 黄鹏兴 | 一种新型的绞股蓝袋泡茶及其制法 |
| CN101569414A (zh) * | 2008-04-29 | 2009-11-04 | 安琪酵母股份有限公司 | 一种富含酵母硒和酵母葡聚糖的组合物 |
| WO2012050895A1 (en) * | 2010-09-28 | 2012-04-19 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
| CN102579768A (zh) * | 2011-01-05 | 2012-07-18 | 李翔 | 一种能增加人体体内一氧化氮合成组方及制备方法 |
| CN102652743A (zh) * | 2011-03-04 | 2012-09-05 | 林飞 | 一种促进人体生成一氧化氮的组方 |
| CN104146248A (zh) * | 2014-07-30 | 2014-11-19 | 广州施健生物科技有限公司 | 一种免疫营养组合物及其应用 |
| CN104187624A (zh) * | 2014-08-07 | 2014-12-10 | 逯明福 | 综合营养粉及其制备方法 |
| CN104187686A (zh) * | 2014-09-26 | 2014-12-10 | 洛阳华以生物工程有限公司 | 一种提高免疫力的保健品 |
| CN104366475A (zh) * | 2014-11-10 | 2015-02-25 | 罗会明 | 一种增强型保健品 |
| CN104784443A (zh) * | 2015-05-04 | 2015-07-22 | 威海御膳坊生物科技有限公司 | 一种辅酶q10复合制剂 |
Non-Patent Citations (2)
| Title |
|---|
| 小慈: "《从头到脚谈养生》", 30 November 2014, 北京联合出版公司 * |
| 康立娟等: "《普通化学 第2版》", 31 July 2005, 高等教育出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109770150A (zh) * | 2019-03-29 | 2019-05-21 | 郑州新福瑞生物科技有限公司 | 一种改善微循环障碍的功能性固体饮料及其制备方法 |
| CN111493258A (zh) * | 2020-04-27 | 2020-08-07 | 郑州瑞普生物工程有限公司 | 一种快速补充能量及营养的固体饮料 |
| CN113317379A (zh) * | 2021-06-21 | 2021-08-31 | 韩孟泽 | 一种保健固态饮料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101579120A (zh) | 一种具有减肥功能的营养食品及其制备方法 | |
| CN101049150A (zh) | 有广泛用途的食用营养保健钾盐 | |
| CN106418545A (zh) | 一种营养均衡的功能性食品 | |
| CN102090563B (zh) | 一种纾压和舒眠的保健食品及其制备方法 | |
| CN102511864B (zh) | 一种红枣浓浆 | |
| CN102048225B (zh) | 一种具有改善生长发育功能的红枣保健饮料 | |
| CN104336144A (zh) | 一种同步调节高血糖高血压高血脂及免疫功能的食用饼干 | |
| CN106993788A (zh) | 全天然蜂王浆含片及其制备方法 | |
| CN105795302A (zh) | 一种调理保健固体饮料 | |
| CN107969541A (zh) | 一种心肌肽压片糖果 | |
| CN103932196A (zh) | 一种葛根营养食品及其制备方法 | |
| CN109430664A (zh) | 一种强芯肽固体饮料 | |
| CN103621871B (zh) | 一种复合氨基酸保健品及其制备方法 | |
| CN103271353B (zh) | 一种护肝保健组合物及其制备方法 | |
| CN102511858A (zh) | 一种适合孕妇食用的红枣浓浆及其生产工艺 | |
| CN102247523B (zh) | 排毒养颜冲剂 | |
| CN101797049B (zh) | 营养八珍汤及其制备工艺 | |
| CN102048134A (zh) | 一种五行蔬菜营养制剂及其制备工艺 | |
| CN103829342A (zh) | 功能性保健饮料及其制备方法 | |
| CN103156244A (zh) | 一种糖尿病人可食用的饮料及其制备方法 | |
| CN103181557A (zh) | 具有减肥功能的营养食品及其制备方法 | |
| CN102511860B (zh) | 一种添加植物甾醇适合孕妇食用的红枣浓浆 | |
| CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 | |
| RU2609874C1 (ru) | Безалкогольный напиток "Комплит Амино Ликвид" | |
| CN105285284A (zh) | 一种灰树花食用菌压片糖果及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160727 |